← Leaderboards
Scott A Weed
University Of Colorado Denver
$3,997,953
Attributed
$4,206,953
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $597.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,206,953 · 10
By mechanism
P20$1,427,429 · 6
R01$1,403,524 · 1
R21$836,000 · 2
K22$540,000 · 1
Top collaborators
- Werner Geldenhuys1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Sana D Karam$9,495,305
- Laurel B Darragh$130,882
- Antonio Jimeno$15,496,689
- Shi-Long Lu$3,811,941
- Kirk C Hansen$5,495,211
Others in their field
Top investigators on “Actins”
- Kathleen M Trybus · University Of Vermont &St Agric College$25,063,493
- David G. Drubin · University Of California Berkeley$23,929,163
- Dennis Brown · Massachusetts General Hospital$21,326,578
- Thomas D. Pollard · Salk Institute For Biological Studies$20,153,634
- Roberto Dominguez · University Of Pennsylvania$19,137,041
- Hugh Lee Sweeney · University Of Pennsylvania$18,810,347
Research focus
ActinsCell MotilityCell LineActin Binding ProteinMalignant NeoplasmsCytoskeletonProteinsHead And Neck Squamous Cell CarcinomaCellsTyrosineNeoplastic CellWestern BlottingsProtein Structure FunctionTumorPhosphorylationHead And Neck CancerOncogenicChromosomesMediating11q13Mouse ModelActin-Binding ProteinNeoplasm MetastasisOverexpression
Grant awards (20)
Targeting CISD1-mediated ferropoptosis in head and neck cancer$418,000
R21 · FY2025 · DE
Evaluation of smoking-associated genes in disparate Appalachian head and neck cancer$190,000
R21 · FY2024 · DE · contact PI
Evaluation of smoking-associated genes in disparate Appalachian head and neck cancer$228,000
R21 · FY2023 · DE · contact PI
ROLE OF CORTACTIN IN HEAD AND NECK CANCER$219,088
P20 · FY2010 · RR · contact PI
ROLE OF CORTACTIN IN HEAD AND NECK CANCER$243,230
P20 · FY2009 · RR · contact PI
ROLE OF CORTACTIN IN HEAD AND NECK CANCER$243,230
P20 · FY2008 · RR · contact PI
Cortactin in Cell Motility and Invasion$311,478
R01 · FY2007 · DE · contact PI
ROLE OF CORTACTIN IN HEAD AND NECK CANCER$248,194
P20 · FY2007 · RR · contact PI
Cortactin in Cell Motility and Invasion$320,781
R01 · FY2006 · DE · contact PI
ROLE OF CORTACTIN IN HEAD AND NECK CANCER$255,606
P20 · FY2006 · RR · contact PI
Cortactin in Cell Motility and Invasion$243,984
R01 · FY2005 · DE
GENOMIC AND PROTEOMIC ANALYSIS OF CORTACTIN IN HNSCC$218,081
P20 · FY2005 · RR
Role of Cortactin in Tyrosine Kinase Signaling$135,000
K22 · FY2005 · DE
Cortactin in Cell Motility and Invasion$135,800
R01 · FY2004 · DE
Cortactin in Cell Motility and Invasion$135,800
R01 · FY2004 · DE
Role of Cortactin in Tyrosine Kinase Signaling$74,556
K22 · FY2004 · DE
Role of Cortactin in Tyrosine Kinase Signaling$60,444
K22 · FY2004 · DE
Cortactin in Cell Motility and Invasion$255,681
R01 · FY2003 · DE
Role of Cortactin in Tyrosine Kinase Signaling$135,000
K22 · FY2003 · DE
Role of Cortactin in Tyrosine Kinase Signaling$135,000
K22 · FY2002 · DE